Re: BETonMACE Enrollment
in response to
by
posted on
Aug 18, 2019 06:54PM
"And the fact that the published report a few weeks back stated "2700 patient years on Apabetalone", which backs out to 2400 on Phase 3 dosed patient years...implying 4800+ patient years for the trial, muddies the picture ever so much."
What published report providing BETonMACE patient year data? I have not seen any published reports on BETonMACE patient years. Please provide your source here.
BearDownAZ